450
Participants
Start Date
October 11, 2020
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2025
Gene expression analysis
Gene expression analysis
Genomic analysis
Genomic analysis
Protein expression analysis
Protein expression analysis
Proteomic profiling
Proteomic profiling
Polymerase chain reaction
Polymerase chain reaction
Mass spectrometry
Mass spectrometry
Immunohistochemistry
Immunohistochemistry
Metabolomics profiling
Metabolomics profiling
Methylation and epigenetic analysis
Methylation and epigenetic analysis
Liquid biopsy analysis
Liquid biopsy analysis, such as cell-free DNA or circulating tumor cell analysis
Laboratory biomarker analysis
Laboratory biomarker analysis (such as AFP, CA19-9, CEA)
RECRUITING
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing
Collaborators (2)
OrigiMed
INDUSTRY
GeneCast Biotechnology Co., Ltd.
INDUSTRY
YuceBio Technology Co., Ltd.
UNKNOWN
Geneplus-Beijing Co. Ltd.
INDUSTRY
Peking Union Medical College Hospital
OTHER